Cytokinetics joins initiative to recognize international rare disease day

Cytokinetics, Incorporated announced that it is joining the European Organisation for Rare Diseases and the National Organization for Rare Disorders, NORD, to recognize Rare Disease Day. “We are proud to be joining EURORDIS, NORD and countless others worldwide to recognize Rare Disease Day and stand in support of those who bravely navigate the complexities and challenges of rare diseases,” said Robert I. Blum, Cytokinetics’ President and Chief Executive Officer. “As we advance aficamten for patients with obstructive hypertrophic cardiomyopathy with regulatory submissions planned to occur later this year, we also remain committed to championing health equity and are supporting activities to help ensure access to education, support, clinical trials and care for those with rare diseases.”